GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedPacto Inc (XKRX:235980) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

MedPacto (XKRX:235980) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to 2019. Start your Free Trial

What is MedPacto Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.


MedPacto Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedPacto Inc (XKRX:235980) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Traded in Other Exchanges
N/A
Address
92 Myeongdal -ro, Seocho-gu, Borim Building, Seoul, KOR
MedPacto Inc is a drug discovery and development company based in South Korea. It is engaged in developing anticancer drugs and medicines which focuses on therapeutics targeting cancer and autoimmune diseases. Its products are in pipeline.